Vaccines News
-
UQ and Vaxxas in Australia win $2 M from US to advance patch-based mRNA COVID-19 vaccine
Vaccines | News | 0 Comment | 14 Jan, 2025
Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...Read more
-
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
Vaccines | News | 0 Comment | 06 Jan, 2025
In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...Read more
-
SK bioscience inks KRW 75.5 B deal with Sanofi to develop next-gen pneumococcal conjugate vaccines
Vaccines | News | 0 Comment | 23 Dec, 2024
South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...Read more
-
Building vaccine and therapeutics manufacturing capacity in Asia Pacific
Vaccines | News | 0 Comment | 20 Dec, 2024
Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...Read more
-
Consortium set to further establish vaccine safety evidence-generation network in Africa
Vaccines | News | 0 Comment | 17 Dec, 2024
A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...Read more
-
Vaccines | News | 0 Comment | 13 Dec, 2024
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...Read more
-
Moderna officially opens new vaccine manufacturing facility in Australia
Vaccines | News | 0 Comment | 10 Dec, 2024
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...Read more
-
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
Vaccines | News | 0 Comment | 03 Dec, 2024
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...Read more
-
Sanofi introduces 'Modulus', world’s first modular manufacturing facility in Singapore
Vaccines | News | 0 Comment | 27 Nov, 2024
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...Read more
-
Korea-Africa partnership for advancing vaccine end-to-end capabilities
Vaccines | News | 0 Comment | 27 Nov, 2024
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...Read more
-
Sanofi, A*STAR and NSC collaborate to advance Acne Vaccine R&D in Singapore
Vaccines | News | 0 Comment | 22 Nov, 2024
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...Read more
-
Vaccines | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 25 Nov, 2024
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...Read more
-
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
Vaccines | News | 0 Comment | 18 Nov, 2024
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...Read more
-
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Vaccines | News | 2 Comment | 29 Oct, 2024
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...Read more
-
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia
Vaccines | News | 0 Comment | 23 Oct, 2024
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...Read more
-
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Vaccines | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more
-
Vaccines | News | 1 Comment | 10 Oct, 2024
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...Read more
-
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology
Vaccines | News | 0 Comment | 08 Oct, 2024
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...Read more
